InvestorsHub Logo
Post# of 4975385
Next 10
Followers 39
Posts 7349
Boards Moderated 0
Alias Born 10/17/2013

Re: dirkv post# 4911294

Monday, 12/05/2022 10:12:19 AM

Monday, December 05, 2022 10:12:19 AM

Post# of 4975385
APRE: 0,544 +13,36%
Volume :133.317

Time for a strong rebound??

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Aprea Therapeutics (APRE - Research Report) and set a price target of $3.00.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.